Neuronetics’ (STIM) “Buy” Rating Reiterated at BTIG Research
BTIG Research reissued their buy rating on shares of Neuronetics (NASDAQ:STIM – Free Report) in a report issued on Wednesday morning,Benzinga reports. The brokerage currently has a $6.00 target price on the stock. Several other brokerages have also weighed in on STIM. Citigroup reissued a “market outperform” rating on shares of Neuronetics in a report […]
12 Sep 01:42 · The Cerbat Gem